MYD88 and rheumatoid arthritis: Our results demonstrated that the blockade of MyD88 dimerization by ST2825 causes cell cycle arrest, reduces invasiveness, downregulates the expression of pain and inflammatory mediators, and upregulates the expression of genes that support mitochondrial function in SFs from RA patients.